drug · cell
patient view →LN-145
Phase 2updated 2mo agoby $IOVA IOVANCE BIOTHERAPEUTICS, INC.🔗 ChEMBL
Phase 2community read0 votes
Cell drug with a maximum clinical stage of Approval (across all indications), with an approval for cutaneous melanoma and 11 investigational indications.
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that